Maternal Health News

Children born to mothers with a hypertensive disorder of pregnancy are not more likely to have childhood asthma than those born to mothers without the disorder, according to a research letter.

Women with vs. without endometriosis using assisted reproductive technology had lower live birth rates, suggesting that uterine receptivity impairments may contribute to infertility mechanisms, researchers reported in JAMA Network Open.

Benzodiazepine use during early pregnancy was associated with almost 70% increased risk for miscarriage after accounting for measurable confounders, according to study results published in JAMA Psychiatry.

For women using IVF/intracytoplasmic sperm injection, SARS-CoV-2 infection within 10 weeks after embryo transfer may not negatively affect pregnancy, implantation and miscarriage rates, researchers reported.

A GSK respiratory syncytial virus vaccine candidate was effective but trials saw a higher incidence in preterm birth, according to research published in the New England Journal of Medicine.

Sources for contraception differed among adolescents and young adults based on sociodemographic factors such as insurance status, age and residential area, according to a research letter published in JAMA Pediatrics.

Distribution of medication for self-managed abortion from sources outside of formal health care settings increased 6 months after the Dobbs decision, despite state-level bans and restrictions, according to findings published in JAMA.

Preeclampsia significantly increases future risk for CVD; however, many women with preeclampsia fail to attend postpartum follow-up visits and, therefore, do not receive proper preventive care.

“Knowledge and understanding of what preeclampsia can do during and after pregnancy and birth is critical.”

Since the Dobbs decision in June 2022, mifepristone has been heavily discussed within legal landscapes regarding its safety, efficacy and availability for women seeking medication abortion.